DK69890A - Monoklonale antistoffer, der er reaktive med cachetin - Google Patents
Monoklonale antistoffer, der er reaktive med cachetin Download PDFInfo
- Publication number
- DK69890A DK69890A DK069890A DK69890A DK69890A DK 69890 A DK69890 A DK 69890A DK 069890 A DK069890 A DK 069890A DK 69890 A DK69890 A DK 69890A DK 69890 A DK69890 A DK 69890A
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibodies
- cachetin
- antibodies reactive
- reactive
- cell lines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22020688A | 1988-07-18 | 1988-07-18 | |
PCT/US1989/003025 WO1990000902A1 (en) | 1988-07-18 | 1989-07-12 | Monoclonal antibodies reactive with cachectin |
Publications (2)
Publication Number | Publication Date |
---|---|
DK69890D0 DK69890D0 (da) | 1990-03-16 |
DK69890A true DK69890A (da) | 1990-05-15 |
Family
ID=22822529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK069890A DK69890A (da) | 1988-07-18 | 1990-03-16 | Monoklonale antistoffer, der er reaktive med cachetin |
Country Status (16)
Country | Link |
---|---|
US (1) | US5658803A (da) |
EP (1) | EP0351789B1 (da) |
JP (1) | JP2638652B2 (da) |
AT (1) | ATE173766T1 (da) |
AU (1) | AU626572B2 (da) |
CA (1) | CA1340018C (da) |
DE (1) | DE68928857T2 (da) |
DK (1) | DK69890A (da) |
ES (1) | ES2124209T3 (da) |
FI (1) | FI101937B (da) |
IL (1) | IL90990A (da) |
NO (1) | NO179615C (da) |
NZ (1) | NZ229922A (da) |
PT (1) | PT91201B (da) |
WO (1) | WO1990000902A1 (da) |
ZA (1) | ZA895372B (da) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5959087A (en) * | 1989-08-07 | 1999-09-28 | Peptide Technology, Ltd. | Tumour necrosis factor binding ligands |
JP3443119B2 (ja) * | 1989-08-07 | 2003-09-02 | ペプテック リミテッド | 腫瘍壊死因子結合リガンド |
US20030225254A1 (en) * | 1989-08-07 | 2003-12-04 | Rathjen Deborah Ann | Tumour necrosis factor binding ligands |
US6498237B2 (en) | 1989-08-07 | 2002-12-24 | Peptech Limited | Tumor necrosis factor antibodies |
GB8918232D0 (en) * | 1989-08-10 | 1989-09-20 | Opal Stephen M | Pharmaceutical product for the treatment of septic shock |
DE69033457T2 (de) * | 1989-08-16 | 2000-09-14 | Chiron Corp | Prohormonspaltungsplatzblockierungsantikörper |
DE4037604A1 (de) * | 1990-04-25 | 1991-10-31 | Bayer Ag | Verwendung von anti-tnf-antikoerpern als arzneimittel bei der behandlung von ischaemien und deren folgen |
EP0592423B1 (en) * | 1990-08-06 | 2000-11-15 | Chiron Corporation | Methods for the identification of cytokine convertase inhibitors |
US5958413A (en) * | 1990-11-01 | 1999-09-28 | Celltech Limited | Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
WO1992011870A1 (en) * | 1991-01-11 | 1992-07-23 | Repligen Corporation | Method of preventing inflammatory damage |
CA2106299C (en) * | 1991-03-18 | 2001-02-06 | Junming Le | Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
US5919452A (en) * | 1991-03-18 | 1999-07-06 | New York University | Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies |
US7192584B2 (en) | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
US5698195A (en) * | 1991-03-18 | 1997-12-16 | New York University Medical Center | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies |
US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
US5656272A (en) * | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
EP0525570A3 (en) * | 1991-07-31 | 1993-10-06 | Miles Inc. | Anti-idiotypic antibodies that mimic tnf |
ATE172880T1 (de) * | 1992-08-28 | 1998-11-15 | Bayer Ag | Verwendung von monoklonalen anti-tnf-antikörpern für die behandlung von bakteriellen meningitiden |
DK0701571T3 (da) * | 1993-06-03 | 1997-09-15 | Therapeutic Antibodies Inc | Antistoffragmenter til terapi |
NZ278607A (en) * | 1994-02-07 | 1999-05-28 | Knoll Ag | Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above |
AU3632595A (en) * | 1994-09-15 | 1996-03-29 | Verigen, Inc | Porcine antibodies to tnf-alpha(alpha) |
US6090382A (en) * | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
CN101712720A (zh) | 1996-02-09 | 2010-05-26 | 艾博特生物技术有限公司 | 结合人TNFα的人抗体 |
DE19746868A1 (de) * | 1997-10-23 | 1999-04-29 | Knoll Ag | Verwendung von TNF-Antagonisten als Arzneimittel zur Behandlung von septischen Erkrankungen |
UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
CA2817619A1 (en) | 2001-06-08 | 2002-12-08 | Abbott Laboratories (Bermuda) Ltd. | Methods of administering anti-tnf.alpha. antibodies |
TWI334439B (en) | 2001-08-01 | 2010-12-11 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
MY150740A (en) | 2002-10-24 | 2014-02-28 | Abbvie Biotechnology Ltd | Low dose methods for treating disorders in which tnf? activity is detrimental |
RU2377253C2 (ru) | 2002-12-02 | 2009-12-27 | Амген Фремонт,Инк. | Антитела, специфичные к фактору некроза опухолей, и их применение |
US20050045635A1 (en) * | 2003-09-03 | 2005-03-03 | Jane Dong | Containers for storing articles |
TW201705980A (zh) | 2004-04-09 | 2017-02-16 | 艾伯維生物技術有限責任公司 | 用於治療TNFα相關失調症之多重可變劑量療法 |
CN101500607B (zh) | 2005-05-16 | 2013-11-27 | 阿布维生物技术有限公司 | TNFα抑制剂治疗腐蚀性多关节炎的用途 |
EP1963367A4 (en) * | 2005-12-06 | 2009-05-13 | Amgen Inc | POLISHING STEPS IN MULTI-STAGE PROTEIN PURIFICATION TREATMENTS |
NZ611859A (en) | 2006-04-05 | 2014-12-24 | Abbvie Biotechnology Ltd | Antibody purification |
US9399061B2 (en) | 2006-04-10 | 2016-07-26 | Abbvie Biotechnology Ltd | Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis |
WO2008063213A2 (en) | 2006-04-10 | 2008-05-29 | Abbott Biotechnology Ltd. | Uses and compositions for treatment of psoriatic arthritis |
US9605064B2 (en) | 2006-04-10 | 2017-03-28 | Abbvie Biotechnology Ltd | Methods and compositions for treatment of skin disorders |
EP2171451A4 (en) | 2007-06-11 | 2011-12-07 | Abbott Biotech Ltd | METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS |
SG187473A1 (en) | 2008-01-15 | 2013-02-28 | Abbott Gmbh & Co Kg | Powdered protein compositions and methods of making same |
US8415291B2 (en) | 2008-10-31 | 2013-04-09 | Centocor Ortho Biotech Inc. | Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
US9334319B2 (en) | 2012-04-20 | 2016-05-10 | Abbvie Inc. | Low acidic species compositions |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
US9505833B2 (en) | 2012-04-20 | 2016-11-29 | Abbvie Inc. | Human antibodies that bind human TNF-alpha and methods of preparing the same |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
US9206390B2 (en) | 2012-09-02 | 2015-12-08 | Abbvie, Inc. | Methods to control protein heterogeneity |
CN104955480A (zh) | 2013-01-25 | 2015-09-30 | 西蒙有限公司 | 用于选择性减少循环的生物活性可溶性tnf的组合物以及用于治疗tnf介导的疾病的方法 |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
EP3052640A2 (en) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
US10465003B2 (en) | 2016-02-05 | 2019-11-05 | Janssen Biotech, Inc. | Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes |
CN110234351A (zh) | 2017-01-30 | 2019-09-13 | 詹森生物科技公司 | 用于治疗活动性银屑病关节炎的抗tnf抗体、组合物和方法 |
JP2020506947A (ja) | 2017-02-07 | 2020-03-05 | ヤンセン バイオテツク,インコーポレーテツド | 活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法 |
BR112021023295A2 (pt) | 2019-05-23 | 2022-02-08 | Janssen Biotech Inc | Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603106A (en) * | 1982-02-22 | 1986-07-29 | The Rockefeller University | Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) |
US4684623A (en) * | 1985-05-02 | 1987-08-04 | The Board Of Trustees Of The Cetus Corporation | Use of tumor necrosis factor as a weight regulator |
US4870163A (en) * | 1985-08-29 | 1989-09-26 | New York Blood Center, Inc. | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
WO1987003489A1 (en) * | 1985-12-05 | 1987-06-18 | Biogen N.V. | Combinations of tumor necrosis factors and antibiotics and methods for treating tumors |
US4834976A (en) * | 1986-07-03 | 1989-05-30 | Genetic Systems Corporation | Monoclonal antibodies to pseudomonas aeruginosa flagella |
DE3631229A1 (de) * | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
-
1989
- 1989-07-12 AU AU39703/89A patent/AU626572B2/en not_active Ceased
- 1989-07-12 JP JP1508080A patent/JP2638652B2/ja not_active Expired - Fee Related
- 1989-07-12 NZ NZ229922A patent/NZ229922A/en unknown
- 1989-07-12 WO PCT/US1989/003025 patent/WO1990000902A1/en active IP Right Grant
- 1989-07-14 ZA ZA895372A patent/ZA895372B/xx unknown
- 1989-07-16 IL IL9099089A patent/IL90990A/en not_active IP Right Cessation
- 1989-07-17 CA CA000605914A patent/CA1340018C/en not_active Expired - Fee Related
- 1989-07-18 EP EP89113170A patent/EP0351789B1/en not_active Expired - Lifetime
- 1989-07-18 ES ES89113170T patent/ES2124209T3/es not_active Expired - Lifetime
- 1989-07-18 PT PT91201A patent/PT91201B/pt not_active IP Right Cessation
- 1989-07-18 AT AT89113170T patent/ATE173766T1/de not_active IP Right Cessation
- 1989-07-18 DE DE68928857T patent/DE68928857T2/de not_active Expired - Fee Related
-
1990
- 1990-03-16 NO NO901247A patent/NO179615C/no not_active IP Right Cessation
- 1990-03-16 FI FI901344A patent/FI101937B/fi not_active IP Right Cessation
- 1990-03-16 DK DK069890A patent/DK69890A/da not_active Application Discontinuation
-
1994
- 1994-12-06 US US08/351,553 patent/US5658803A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL90990A (en) | 1994-10-21 |
ZA895372B (en) | 1990-04-25 |
EP0351789A3 (en) | 1990-08-01 |
ES2124209T3 (es) | 1999-02-01 |
NO179615C (no) | 1996-11-13 |
WO1990000902A1 (en) | 1990-02-08 |
EP0351789B1 (en) | 1998-11-25 |
NO901247D0 (no) | 1990-03-16 |
DE68928857T2 (de) | 1999-08-05 |
AU626572B2 (en) | 1992-08-06 |
ATE173766T1 (de) | 1998-12-15 |
EP0351789A2 (en) | 1990-01-24 |
DE68928857D1 (de) | 1999-01-07 |
NO179615B (no) | 1996-08-05 |
DK69890D0 (da) | 1990-03-16 |
NO901247L (no) | 1990-03-16 |
US5658803A (en) | 1997-08-19 |
AU3970389A (en) | 1990-02-19 |
FI101937B1 (fi) | 1998-09-30 |
PT91201A (pt) | 1990-02-08 |
FI101937B (fi) | 1998-09-30 |
NZ229922A (en) | 1992-04-28 |
JP2638652B2 (ja) | 1997-08-06 |
PT91201B (pt) | 1996-12-31 |
CA1340018C (en) | 1998-09-01 |
JPH03501330A (ja) | 1991-03-28 |
IL90990A0 (en) | 1990-02-09 |
FI901344A0 (fi) | 1990-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK69890A (da) | Monoklonale antistoffer, der er reaktive med cachetin | |
DE68929279T2 (de) | Lederbehandlung mit ausgewählten amphiphilen Copolymeren | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
DE68912334T2 (de) | Immunokonjugate für krebs-diagnose und -therapie. | |
FR2631239B1 (fr) | Anticorps monoclonal humain et hybridome le produisant | |
FI853389L (fi) | Tumoerlaekemedel och foerfarande foer dess framstaellning. | |
EP0339163A3 (en) | Monoclonal antibodies specific for hiv and hybridomas for their production | |
DE3585049D1 (de) | Monoklonale antikoerper. | |
ES2061566T3 (es) | Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo. | |
EP0042428A4 (en) | PURIFIED ANTIGEN OF HUMAN PROSTATE. | |
EP0166458A3 (en) | Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells | |
IL91649A0 (en) | Hybrid monoclonal antibodies,their production and use | |
DE69129582T2 (de) | Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay | |
TR25221A (tr) | ISLAH EDILMIS YUMUSAKLIGA SAHIP YAGLANMIS DERILER VE BUNLARIN üRETILMESINE MAHSUS USUL. | |
BE866442A (fr) | Dispositif d'obturation de soupapes, vannes et similaires et soupapes, vannes equipees de ce dispositif | |
EP0272113A3 (en) | Anti-human cancer monoclonal antibodies | |
ATE99332T1 (de) | Monoklonale antikoerper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen. | |
ATE84069T1 (de) | Murin-hybridoma lym-2 und diagnostikantikoerper, der dadurch hergestellt ist. | |
FI880188A0 (fi) | Wobbler med flere funktioner. | |
DE295305T1 (de) | Monoklonaler antikoerper, spezifisch gegen tumorzellenoberflaechengangliosid und denselben herstellendes hydridom. | |
ES1006440Y (es) | Plantilla terapeutica. | |
IT7921302V0 (it) | Parasole per autoveicoli e simili, regolabile. | |
DE3484851D1 (de) | Inkontinentenvorlage mit elastischem balg. | |
NO885357D0 (no) | Baufilblad med tosidig tanning. | |
IT8215234V0 (it) | Schermo riflettente per l abbronzatura solare completa ed omogenea del corpo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |